Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Risk quotient, development

In the case of noncarcinogenic substances, there exists a threshold this is an exposure with a dose below which there would not be adverse effect on the population that is exposed. This is the reference dose (RfD), and it is defined as the daily exposure of a human population without appreciable effects during a lifetime. The RfD value is calculated by dividing the no observed effect level (NOEL) by uncertainty factors. When NOEL is unknown, the lowest observed effect level (LOEL) is used. NOEL and LOEL are usually obtained in animal studies. The main uncertainty factor, usually tenfold, used to calculate the RfD are the following the variations in interspecies (from animal test to human), presence of sensitive individuals (child and old people), extrapolation from subchronic to chronic, and the use of LOEL instead of NOEL. Noncancer risk is assessed through the comparison of the dose exposed calculated in the exposure assessment and the RfD. The quotient between both, called in some studies as hazard quotient, is commonly calculated (Eq. 2). According to this equation, population with quotient >1 will be at risk to develop some specific effect related to the contaminant of concern. [Pg.97]

To assess tlie overall potential for noncarcinogenic effects posed by more dian one chemical, a liazard index (HI) approach has been developed based on EPA s Guidelines for Healdi Risk Assessment of Chemical Mixtures. This approach assumes that simultaneous subtlu eshold exposures to several chemicals could result in an adverse healtli effect. It also assumes tliat tlie magnitude of the adverse effect will be proportional to tlie sum of the ratios of the subtlireshold exposures to acceptable exposures. The non cancer hazard index is equal to tlie sum of the hazard quotients, as described below, where E and tlie RfD represent the same exposure period (e.g., subclironic, clironic, or shorter-term). [Pg.399]

Although activation of the AHR by DLCs is a key event, mechanistic data indicate that AHR-mediated responses are not well conserved across species, with lower sensitivity in humans. A TEF value for a DLC based on rodent data may overestimate the potency of a DLC in humans, and this has not been considered in the current risk assessment of DLCs. Thus, the current TEF-Toxic Equivalency Quotient scheme tends to compound the conservative estimates of risk that exist within standard risk assessment approaches. Moreover mechanistic differences will now be considered by US EPA in the risk assessment of chemical carcinogens. The mechanistic data currently available for receptor-mediated DLCs and PPs clearly indicate that humans respond differently to these two classes of rodent carcinogens, and these data will need to be incorporated into cancer risk assessments for these chemicals. Full appreciation of the species differences in these receptor mechanisms will require continued development and refinement of models such as primary... [Pg.91]

Hazard Index Approach A chemical mixtures risk assessment method where hazard quotients for component chemicals are only developed using the critical effect. Hazard quotient values are grouped by critical effect and summed. Multiple hazard indexes are developed, one for each affected target organ or system. [Pg.620]

The risk characterization step involves two components risk estimation and risk description. The risk estimation component is similar to the hnman health risk characterization conducted for non-cancer effects of chemicals in that it qnantifies potential effects from chemical exposure. Depending on the methods nsed to estimate exposure and toxicity, the methods nsed in risk estimation for ecological receptors may differ from those used for humans. One method that can be used, which is similar to the method used for humans, is the toxicity quotient method. In this method, the estimated exposure is divided by a safe level of exposure developed in the characterization of effects component. The resulting value is compared to a threshold level of one. Below this level, no effects are expected (regardless of what the impact might be). Above this level, there may be effects. [Pg.124]


See other pages where Risk quotient, development is mentioned: [Pg.364]    [Pg.42]    [Pg.61]    [Pg.62]    [Pg.641]    [Pg.7]    [Pg.168]    [Pg.171]    [Pg.586]    [Pg.606]    [Pg.610]    [Pg.100]    [Pg.702]    [Pg.471]    [Pg.608]    [Pg.353]   
See also in sourсe #XX -- [ Pg.35 ]




SEARCH



Development risks

Quotient

© 2024 chempedia.info